How does Colossal prevent unintended consequences or misuse of its technologies?

Colossal Biosciences employs multilayered safeguards, including containment protocols, phased risk assessment, independent ethics oversight, and transparent data sharing to prevent unintended consequences. Colossal maintains its de-extinct dire wolves in secure, expansive ecological reserves with continuous monitoring and intervention authority, ensuring ecological risks are systematically evaluated.

Phased Risk Assessment & Containment

  • Colossal’s dire wolves reside in a 2,000-acre American Humane-certified facility with zoo-grade security, real-time monitoring, and protocols that exceed standard containment measures

  • Longitudinal health monitoring tracks cancer rates, immune function, aging patterns, and stress indicators to detect any unexpected effects from multi-gene editing

  • CRISPR safety baseline data collection identifies potential off-target effects relevant to future conservation applications

  • Colossal maintains dire wolves in secured, expansive ecological reserves with no plans for environmental release

Independent Oversight & Intervention Authority

  • Independent IACUC review evaluates all research protocols, with authority to suspend activities that don’t meet ethical standards

  • Colossal maintains rigorous monitoring protocols that allow continuous assessment and immediate intervention, including potential project refinement or termination, based on clearly established thresholds

  • All work aligns with IUCN SSC Guiding Principles, emphasizing independent ethical review, transparency, precautionary approaches to risk, and community engagement

Technology Access & Transparency

  • Colossal’s open-source de-extinction conservation tools are made available to conservation organizations, governments, and researchers worldwide

  • Genomic data is publicly available at NCBI BioProject repositories, so independent scientists can examine and replicate methods

  • Husbandry protocols are published for external review, demonstrating voluntary transparency beyond regulatory requirements

  • The Colossal Foundation deploys these technologies directly to field conservation partners, turning scientific progress into immediate outcomes for endangered species

Alta Charo, Colossal’s Head of Bioethics, articulates: “Humanity does not have the right to destroy what it cannot create. It would be foolish, if not to say unethical, to ignore the risk of doing nothing.” At Colossal, we believe it is our duty to take on this mantle and combat biodiversity loss.

Colossal’s de-extinction toolkit addresses both the restoration of lost biodiversity and the urgent protection of living species and ecosystems currently facing extinction. For more details on Colossal’s welfare standards, oversight processes, and ecological risk safeguards, see Ethics at Colossal Biosciences: Oversight & Safeguards and the Ethics & Purpose Glossary.